Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03569020 · ClinicalTrials.gov registry record · NA
The Diet Gout Trial
A NA study of Gout and Hyperuricemia, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 2
- Study locations
NCT03569020: Completed NA study of Gout and Hyperuricemia, sponsored by Johns Hopkins University.
NCT03569020 is a NA study of Gout and Hyperuricemia that has completed, run by Johns Hopkins University. The registered enrollment target is 43 participants, below the 8,887-participant average among 34 other Gout trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03569020, a NA study of Gout and Hyperuricemia, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 2
- Study locations
Study Summary
Unhealthy diet has long been associated with high uric acid levels and gout. The DASH diet may lower uric acid levels. This study will examine the effects of the DASH diet on uric acid in adults with a history of gout.
Primary Outcome
Measured in serum
Conditions Studied
Interventions
- OTHER Subsidy for food purchases and dietitian education
Study Locations (2)
Maryland
- Johns Hopkins ProHealth Research Clinic - Woodlawn
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2018-08-07 |
| Est. Completion | 2019-07-23 |
| Phase | NA |
What the finished NCT03569020 record still lists
NCT03569020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 8,887-participant average among 34 other Gout trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Gout appearing as the primary indexed condition, and to 1 intervention - of which Subsidy for food purchases and dietitian education is the first listed.
NCT03569020 reports a single indexed study location in Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03569020 about?
NCT03569020 is a clinical study titled "The Diet Gout Trial". Unhealthy diet has long been associated with high uric acid levels and gout. The DASH diet may lower uric acid levels. This study will examine the effects of the DASH diet on uric acid in adults with a history of gout.
What is the current status of trial NCT03569020?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2018-08-07. Estimated completion is 2019-07-23.
What conditions does trial NCT03569020 study?
This clinical trial studies the following conditions: Gout, Hyperuricemia.
What interventions are being tested in trial NCT03569020?
The interventions under investigation include: Subsidy for food purchases and dietitian education (OTHER).
Who is sponsoring clinical trial NCT03569020?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03569020 being conducted?
This trial has 2 study locations across Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gout
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03569020's enrollment target sits among peer trials
43 22nd of 34 higher than 13 of 34 other Gout trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gout trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response of Exercise for Arthritis Management
RECRUITING · NA
-
Improving Gout Care After an ED Visit
RECRUITING · NA
-
Gout in the ED and Improving Research Participation
ACTIVE NOT RECRUITING · NA
-
Novel Methods for Ascertainment of Gout Flares -A Pilot Study
COMPLETED · NA
-
Pharmacokinetics and Pharmacodynamics of Anthocyanins
COMPLETED · NA
-
UR+AIMS Gout Wearable Skin Uric Acid Monitor Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI